Neuroprotective Efficacy of the Peroxisome Proliferator-Activated Receptor-&ggr; Ligand in Chronic Cerebral Hypoperfusion

Publisher： Bentham Science Publishers

E-ISSN： 1875-5739|8|3|190-199

ISSN： 1567-2026

Source： Current Neurovascular Research, Vol.8, Iss.3, 2011-08, pp. : 190-199

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peroxisome Proliferator-Activated Receptor- Activation Protects Brain Capillary Endothelial Cells from Oxygen-Glucose Deprivation-Induced Hyperpermeability in the Blood-Brain Barrier

By  

Current Neurovascular Research, Vol. 6, Iss. 3, 2009-08 ,pp. : 181-193

Bentham Science Publishers

Access to resources Recommend Favorite

Chronic Cerebral Hypoperfusion Protects Against Acute Focal Ischemia,Improves Motor Function, and Results in Vascular Remodeling

By  

Current Neurovascular Research, Vol. 5, Iss. 1, 2008-02 ,pp. : 28-36

Bentham Science Publishers

Access to resources Recommend Favorite

Enriched Environment Prevents Cognitive Impairment and Tau hyperphosphorylation after Chronic Cerebral Hypoperfusion

By  

Current Neurovascular Research, Vol. 9, Iss. 3, 2012-01 ,pp. : 176-184

Bentham Science Publishers

Access to resources Recommend Favorite

Preconditioning with Chronic Cerebral Hypoperfusion Reduces a Focal Cerebral Ischemic Injury and Increases Apurinic/Apyrimidinic Endonuclease/Redox Factor-1 and Matrix Metalloproteinase-2 Expression

By  

Current Neurovascular Research, Vol. 4, Iss. 2, 2007-05 ,pp. : 89-97

Bentham Science Publishers

Access to resources Recommend Favorite

Angelica Injection Reduces Cognitive Impairment during Chronic Cerebral Hypoperfusion through Brain-Derived Neurotrophic Factor and Nerve Growth Factor

By  

Current Neurovascular Research, Vol. 5, Iss. 1, 2008-02 ,pp. : 13-20

Bentham Science Publishers

Access to resources Recommend Favorite